Advertisement

Related Videos

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Advertisement

Advertisement




Jul
13
Today In Oncology
Breast Cancer: Tailoring Radiotherapy Based on Nodal Response to Primary Chemotherapy
Novel Gene Therapy–Radiotherapy Combination in Localized Prostate Cancer
Advanced Breast Cancer Novel CDK4/6 Inhibitor Plus an Aromatase Inhibitor
Emergency Hospital Admission Accounts for 40 of Ovarian Cancer Diagnoses in England
Perioperative Systemic Therapy vs Surgery Alone in Colorectal Peritoneal-Only Metastases
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo